Analyst Conference Summaries

Biotechnology Investor Aids

Acceleron Pharma
XLRN

conference date: May 9, 2019 @ 2:00 PM Pacific Time

Acceleron: Luspatercept New Data Is A Buy Signal [June 7, 2018, Seeking Alpha]

Acceleron Pharma (XLRN) has 2 Potential Blockbusters [July 22, 2015, Seeking Alpha]

Analyst Conference Notes by William P. Meyers
2019
Acceleron
XLRN
Q1 2019
     
May 9, 2019      
2018
Acceleron
XLRN
Q4 2018
May 8, 2018
Aug. 2, 2018
Oct. 30, 2018
Feb. 27, 2019
2017
May 8, 2017
August 3, 2017
Nov. 7, 2017
Feb. 27, 2018
2016
05/05/2016
08/04/2016
11/03/2016
03/01/2017
2015
 

 
11/04/2015 
02/25/2016

Acceleron Pharma is a development stage biotechnology company.

Acceleron Pharma web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INCY
 INO
 ISRG
 MCHP
 MYL
 PLX
 REGN
 SGEN
 TTPH
 VBLT
 VSTM
 XLNX
 XLRN

 
 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.

Copyright 2019 William P. Meyers